Sanofi (SNY) Tops Q2 EPS by 5c

Sanofi (NYSE: SNY) reported Q2 EPS of EUR1.25, EUR0.05 better than the analyst estimate of EUR1.20. Revenue for the quarter came in at EUR8.18 billion versus the consensus estimate of EUR8.36 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30